Comparative outcomes of systemic diseases in people with type 2 diabetes, or obesity alone treated with and without GLP-1 receptor agonists: a retrospective cohort study from the Global Collaborative Network
Mahmoud Nassar, Omar Nassar, Hazem Abosheaishaa, Anoop Misra
Topics & Concepts
Type 2 diabetesMedicineGlucagon-like peptide 1 receptorGlycemicObesityDiabetes mellitusGlucagon-like peptide-1Retrospective cohort studyAgonistInternal medicineIntensive care medicineEndocrinologyPharmacologyReceptorDiabetes Treatment and ManagementInflammatory Bowel DiseaseMicroscopic Colitis